Discover how the FDA’s final rule on classifying the device to detect bacterial protease activity in chronic wound fluid impacts regulatory compliance and innovation. This course covers the significance of the class II designation with special controls and the benefits of the De Novo process in reducing regulatory burdens, ensuring patient safety, and enhancing access to innovative medical solutions.
In this course you will learn the following:
* Understand the classification process and criteria for the device.
* Identify the special controls required for compliance.
* Recognize the benefits of the De Novo classification process in reducing regulatory burdens.
Class II Classification of Devices Detecting Bacterial Protease in Wound Fluid
$9.99
1 year of access
Course Content
Class II Classification of Devices Detecting Bacterial Protease in Wound Fluid
